CGA and neuroendocrine neoplasm: Increased levels of CgA have been identified in the blood of patients suffering from carcinoids or other neuroendocrine tumors (10–14), heart failure, renal failure, hypertension, rheumatoid arthritis, and inflammatory bowel disease (15–23), indicating an important role of CgA to influence human health and disease (24).